Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Glad to see COVIMSC advance in the US and Brazil. And that it is being tested both in "rescuing" people from Covid cytokine storm AND to help the "recovery" of Covid long-haulers. Both are very large unmet needs!

We could get ABIVERTINIB Covid cytokine storm "prevention" results from the US and Brazil later this month. If it is successful it is another enormous unmet need.

The next important treatment news could be about COVIDROPS. These nasal drops would be a treatment game changer. They are undergoing interesting trials in several jurisdictions including the UK.

COVIMSC, ABIVERTINIB and COVIDROPS each have enormous worldwide potential. Each would warrant EUA approvals and would likely attract worldwide marketing partnerships.

These near term results plus the PSS arbitration results and the pivotal SP-102 results make for an interesting Q4 2021 and Q1 2022.